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Editorial
Colony Collapse Disorder May Affect Complementary
and Alternative Medicine
Edwin L. Cooper
Laboratory of Comparative Neuroimmunology, Department of Neurobiology, David Geffen School of
Medicine at UCLA, Box 951763, 63-230 CHS, Los Angeles California 90095-1763, USA
Very recently some surprising and puzzling news
appeared in the media: television and newspapers,
reporting a phenomenon perhaps akin to a population
crash. It sounded like a pandemic in that it occurs over a
large area of the world—not an epidemic, an outbreak of
a disease that spreads rapidly through a community. The
news caught my immediate attention since the affected
population particularly concerns my initiative to advance
bioprospecting (1) and more specifically biotherapy
(I lectured at the VII Biotherapy Congress, Seoul
Korea, June 20–25, 2007). From the inception of
eCAM there has been a conscious effort to capture or
focus on the beneficial effects of natural products,
especially those derived from marine and terrestrial
animals. The jolting news concerns honeybees and a
phenomenon referred to as Colony Collapse Disorder
(CCD), a disorder in which disturbing numbers of bees
are disappearing from their colonies. This is of great
interest for the basic science and application of products
from honeybees and the broader context of agriculture
and CAM.
Of all the printed media, the most appropriate coverage
was featured in The Economist, April 28, 2007, page 92.
One article was entitled: ‘Dying bees buzz off’ and the
other: ‘Medical use of honey: Sticky solution’. Actually
neither of these articles mention propolis, the product of
honeybee activity that is the focus of some of eCAM’s
most popular articles (2–9). According to the first article,
CCD, as the phenomenon has become known, was first
reported in America in mid-November 2006. It spread
rapidly with beekeepers reporting heavy losses of between
30 and 90% of bees. Some 24 American states have now
reported cases of CCD. It has also been seen in Greece,
Italy, Poland, Portugal and Spain. Because the living bees
that scientists were able to analyze carried almost every
virus and parasite known to infect honeybees, researchers
are working on the idea that the insects’ immune systems
have failed. Reduction in the body’s ability to fight
diseases allows infection by a host of pathogens. But
exactly why this should happen is unclear. It could be
that one disease, perhaps a new type of ‘lurgy’, invites the
others to infect the bee, or that a pesticide performs this
role. The researchers interviewed beekeepers to determine
if some practices were more likely to lead to CCD.
At first they found that beekeepers who frequently
moved their hives seemed to have bees that were more
likely to be affected. Perhaps this constant moving
is stressful for the bees and so depresses their immune
systems.
In the companion article the thrust is more towards
what the bees’ product, honey, can offer. ‘Hospitals do
more than house sick patients while they are treated.
They also provide convenient havens for dangerous
bacteria. Cramming infirm people into one place creates
the ideal breeding ground for disease. Add a sprinkling
of antibiotics and drug-resistant strains emerge—the
superbugs that are endemic in many places. One
doctor, however, thinks he has rediscovered an old
weapon that could be useful in the fight against these
nasties. It is honey. Honey was commonly used in
medicine before antibiotics became widespread. It is still
used in the Antipodes; an Australian company makes
a product called Medihoney for medicinal use. This
formulation is a certified medicine in Europe, but has not
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properly cited.been much used there because doctors developed a taste
for prescribing conventional antibiotics. Arne Simon of
Bonn University Children’s Clinic in Germany is now
leading an international study to compare honey with
existing drugs. The investigation will involve 150 patients
in several countries including Britain, Germany and
Australia. Dr Simon has already used honey on 150
patients who were not responding to treatment, with
some promising results. The patients were often children
whose immune systems had been weakened by che-
motherapy, which left their wounds from surgery vulner-
able to infection. Around a third of them were also given
some antibiotics at the same time as having their wounds
dressed with honey. One patient, whose wounds had
become infected by the potentially fatal strain of
Staphylococcus aureus that is resistant to the antibiotic
methicillin (MRSA), and who failed to respond to other
drugs, was free of this superbug within 48 hours of
receiving the honey treatment.’ This excerpt has now
been expanded (10).
Turning now to eCAM, we have targeted papers
dealing with propolis. All the investigators agree essen-
tially on the nature of propolis as a product of honeybees
and they reveal variable composition depending on the
country of origin. Propolis is a hive product containing
chiefly beeswax and plant-derived substances such as
resin and volatile compounds. Propolis has been used as
an antiseptic and wound healer since ancient times and
interest for the product has increased recently. Probably
few plant species contribute as major resin sources. Green
propolis derives mainly from vegetative apices of
Baccharis dracunculifolia (alecrim plants). However,
wide variation detected in the chemical composition
suggests contributions from alternative resin plant
sources. Predominant components of the resin of green
propolis are cinnamic acids, chiefly compounds bearing
prenyl groups. Terpenoid compounds, such as sesqui,
di and pentacyclic triterpenoids, have been detected in
many, but not all, samples investigated. Propolis research
has uncovered potentialities of substances previously
isolated from plants and has detected constituents of
plant origin that would hardly be known otherwise.
Analyses also focus on various assays designed to test the
efficacy especially viewing in vitro models. Certain studies
merit more attention as they focus on the nervous and
immune systems.
Inokuchi et al. (7), confirm that propolis has gained
popularity as a food and alternative medicine. Its
constituents have been shown to exert pharmacological
(anticancer, antimicrobial and anti-inflammatory) effects.
They investigated whether Brazilian green propolis exerts
neuroprotective effects in the retina in vitro and/or in
vivo. Propolis inhibited the neurotoxicity and apoptosis
induced in cultured retinal ganglion cells. These findings
indicate that Brazilian green propolis has neuroprotective
effects against retinal damage both in vitro and in vivo,
and that a propolis-induced inhibition of oxidative
stress may be partly responsible for these neuroprotective
effects.
According to Missima and Sforcin (9), stress is a gene-
ric term that summarizes how psychosocial and environ-
mental factors influence physical and mental well-being.
The interaction between stress and immunity has been
widely investigated, involving the neuroendocrine system
and several organs. Assays using natural products in
stress models deserve further investigation. Propolis’
immunomodulatory action has been mentioned and it
has been the subject of scientific investigation. They
evaluated if and how propolis activated macrophages
in BALB/c mice submitted to immobilization stress, as
well as the histopathological analysis of the thymus,
bone marrow, spleen and adrenal glands. Stressed mice
showed a higher hydrogen peroxide (H2O2) generation by
peritoneal macrophages, and propolis treatment poten-
tiated H2O2 generation and inhibited nitric oxide (NO)
production by these cells. Histopathological analysis
showed no alterations in the thymus, bone marrow and
adrenal glands, but increased germinal centers in the
spleen. Propolis treatment counteracted the alterations
found in the spleen of stressed mice. New research is
being carried out in order to elucidate propolis’
immunomodulatory action during stress.
In summary, what does all of this mean? CCD is real
but its cause is unknown despite plausible ideas such as
stress that may weaken the honeybee’s immune system.
Most importantly these citations and media reports about
CCD will perhaps have a longer term or later effect on
CAM—of course the immediate being possible severe
effects on aspects of the agricultural industry. Estimates
in the billions of dollars underscores our reliance on bees
for honey production and pollination of fruits, vegetables
and nuts, especially the multi-billion dollar almond crops
(11). Because of this threat to bees are we thinking of
ways to mimic the honeybees’ ability in pollinating? If the
beginning devastation caused by CCD continues will we
create a newer synthetic mechanized honeybee capable
of pollination that could thus facilitate other biomedical
practices associated with Apis that have become so
essential to CAM? And apitherapy is wide ranging (12).
To give you an idea of what the world would lose with
the disappearance of the bee, I refer to the website of
<apimondia.org> in which the hive is called ‘the oldest
laboratory of the world.’ In that site, the myriad aspects
of honey, bee bread, propolis, royal jelly, bee venom, bee
wax and bee larvae are linked to treatments of all the
major pathologies from nutritional problems to arthritis,
rheumatism and 23 other areas. Of course, all these
treatments do not have an evidence base but imagine how
fertile the hive and its products are for evidence-based
research! In this time of crisis, I hope that scientists all
over the world turn their brilliant minds to the mystery of
CCD and that researchers continue to seek an evidence
276 Editorialbase for the miraculous honey bee. And as you can see
by our past issues, eCAM is a bee-friendly publication.
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